Data de publicação: 29/04/2024 - 12:15
Pasteur Fiocruz Center for Immunology and Immunotherapy
Address
Rua São José, S/N - Precabura, Eusébio - CE, 61773-270, Brasil
Contacts
Center's secretariat
Phone: +55 (85) 3215-6980
Email: adm.cpfii@fiocruz.br
Press (TBD)
Phone:
Email:
Páginas Institucionais para Especiais
Data de publicação: 05/02/2024 - 16:53
The Pasteur Network has announced the election of new regional representatives for the Americas, Africa, Asia-Pacific, and Euro-Mediterranean. Among the elected representatives is Mario Moreira, the president of Fiocruz. Alongside Carlos Bathhyany, from the Pasteur Institute in Montevideo, he will represent the Americas. The newly elected representatives will serve two-year terms and become part of the Board of Directors of the Association....
Notícias
Data de publicação: 29/04/2024 - 12:15
The Center's activities include organizing courses and other innovative bilateral and multilateral academic activities in the areas of expertise covered by the researchers involved in the cooperation.
Check back here for upcoming opportunities.
Páginas Institucionais para Especiais
Data de publicação: 29/04/2024 - 12:14
The Pasteur-Fiocruz Center for Immunology and Immunotherapy works in three priority scientific areas: cancer, infectious and neglected diseases, and autoimmune, neurodegenerative and inflammatory diseases.
Research groups and associated projects:
1) Structural computational biology (João Hermínio Martins da Silva Sena).
Associated projects:
- Development of inhibitors for the treatment of neurodegenerative diseases...
Páginas Institucionais para Especiais
Data de publicação: 29/04/2024 - 12:14
The Pasteur Fiocruz Center on Immunology and Immunotherapy brings together scientists from the Institut Pasteur and Fiocruz to develop integrative approaches to improve the treatment of infectious diseases, such as COVID-19, and non-communicable diseases, such as cancer, using immunotherapies, considered an important public health strategy.
Immunotherapy is a treatment that dynamically modulates the immune system, promoting the body's...
Páginas Institucionais para Especiais
Data de publicação: 29/04/2024 - 12:13
The Pasteur Fiocruz Center on Immunology and Immunotherapy is a collaborative project between the Institut Pasteur and Fiocruz that brings together researchers from the institutions with an integrative approach to improving the treatment of infectious and non-communicable diseases through immunotherapy.
Located at Fiocruz Ceará, in Eusébio, in the Metropolitan Region of Fortaleza, the Center has a laboratory structure and...
Páginas Institucionais para Especiais
Data de publicação: 22/04/2024 - 16:10
Fiocruz has taken another important step towards strengthening and implementing institutional initiatives and policies in favor of ethnic-racial and gender equity, diversity and inclusion. On Tuesday and Wednesday (April 11th and 12th, 2023), the Foundation launched the Ethnic-Racial and Gender Equity Policy and presented to the internal community the new Coordination of Equity, Diversity, Inclusion and Affirmative Policies (Cedipa), established...
Notícias
Data de publicação: 25/04/2024 - 15:30
A study led by the Oswaldo Cruz Institute (IOC/Fiocruz) in partnership with British institutions opens the door to the development of new treatments for schistosomiasis. The disease affects 200 million people in 78 countries, including Brazil. It also belongs to the group of neglected diseases, which are associated with poverty and receive low investment in prevention, diagnosis and treatment from the pharmaceutical industry and public policies...
Notícias
Data de publicação: 11/04/2024 - 11:14
A survey of indigenous Yanomami people, from the Ninam subgroup, from nine villages located in Roraima, showed that all participants were contaminated by mercury. The highest levels of exposure were detected in indigenous people living in the villages closest to the illegal gold mines. The study Impact of Mercury on Protected Areas and Forest Peoples in the Amazon: An Integrated Health-Environment Approach was conducted by the Sergio Arouca...
Notícias
Data de publicação: 16/08/2023 - 16:25
Fiocruz reaffirms its commitment and institutional policy to deepen affirmative and inclusive actions for the country's indigenous populations, through partnerships that offer access to education. The Leônidas & Maria Deane Institute (Fiocruz Amazônia) launched last Monday (8/14) the first master's degree course in Collective Health aimed exclusively at training indigenous professionals, teachers and researchers from Alto...
Notícias
Data de publicação: 05/03/2024 - 16:07
The Institute of Drug Technology (Farmanguinhos/Fiocruz) announced in 2/28 a partnership agreement with the Brazilian unit of the German pharmaceutical company Boehringer Ingelheim in Rio de Janeiro. This is the first step towards submitting and obtaining registration for a generic product of Jardiance®, empagliflozin 10 mg and 25 mg, with the Brazilian Health Regulatory Agency (Anvisa). The drug is indicated for the treatment of adults with...
Notícias
Data de publicação: 05/03/2024 - 15:43
Living on an extremely low income is a risk factor for a variety of health conditions, such as tuberculosis, malaria and AIDS. Previous studies have shown that public policies such as conditional cash transfer programs are among the most effective interventions for improving the well-being of individuals and families in low- and middle-income countries living in situations of vulnerability. A study published in the scientific journal Nature...
Notícias
Data de publicação: 11/04/2024 - 10:02
In front of representatives from 24 countries, Fiocruz opened on 4/3, and hosted until 4/5, the Second Global Workshop for countries presenting Voluntary National Reviews (VNRs), part of a series of three meetings organized by the United Nations to draw up proposals to be taken to the UN High-Level Political Forum on Sustainable Development (HLPF) in July. This is the first time the workshop has been held in Latin America, and its opening was...
Notícias
Data de publicação: 16/04/2024 - 14:30
Fiocruz Pernambuco has created a 100% national ingredient to be added to the rapid screening test for the diagnosis of visceral leishmaniasis (VL). The product can be used for both the human and canine populations, being the first with this dual efficacy. The product has already been assessed in laboratories and will soon be implemented in the field. VL is an infectious disease transmitted by the drain fly that can affect both humans and animals...
Notícias
Data de publicação: 16/04/2024 - 15:33
The Laboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies of the Oswaldo Cruz Institute (IOC/Fiocruz) is part of a new cooperation network of the World Health Organization (WHO) to monitor the different types of coronavirus. Called CoViNet, the initiative is an offshoot of the network of reference laboratories set up by WHO at the start of the public health emergency caused by Sars-CoV-2. The group brings together...
Notícias
Data de publicação: 29/02/2024 - 12:27
There are different parameters for assessing a child's development from birth, and weight and height gain is some of these factors. However, there are indirect influences that act on this factor of development. This is what a new study published by researchers from the Center for Data and Knowledge Integration for Health (Cidacs/Fiocruz Bahia) points out. The research findings suggest that the ethnicity/color of pregnant women affects the...
Notícias
Data de publicação: 29/02/2024 - 12:03
Fiocruz and the Federal University of Rio de Janeiro (UFRJ) signed an agreement last Wednesday (2/21) to set up a research center in the UFRJ Technology Park. The partnership between the institutions will allow setting up an innovation-promoting environment in the form of a health technology platform, aimed at developing products, services and technologies to meet the demands of the Unified Health System (SUS). Present at the signing ceremony...
Notícias
Data de publicação: 03/04/2024 - 16:03
The Institute of Technology on Immunobiologicals (Bio-Manguinhos/Fiocruz) and the pharmaceutical company Sanofi signed a Memorandum of Understanding last Wednesday (3/27) that reaffirms their mutual interest in establishing further collaborations in the field of immunization. In January this year, the institutions signed a technology transfer agreement for the domestic production of the acellular hexavalent vaccine. The immunizer offers...
Notícias
Data de publicação: 27/03/2024 - 14:05
The historic Fiocruz complex in Manguinhos, in Northern Rio de Janeiro, is a candidate for World Heritage status by the United Nations Educational, Scientific and Cultural Organization (UNESCO). The institution is now part of the tentative list of sites that can become Cultural, Natural and Mixed World Heritage Sites, a primary and obligatory stage for any property to begin the process of recognition.
Inscription of the historical complex...
Notícias
Data de publicação: 16/04/2024 - 15:12
Fiocruz hosted, from April 8th to 12th, the Fiocruz-Pasteur Network International Course on bioproduction, intellectual property and technology transfer. In the auditorium of the Rocha Lima Pavilion, on the Manguinhos Campus in Rio de Janeiro, 11 foreign students and 7 students from different units of the Foundation discussed topics such as research, development, production, quality control, clinical studies, regulatory issues and the...
Notícias
Data de publicação: 12/04/2024 - 11:02
During dengue epidemics, the resulting deaths, with rare exceptions, are avoidable. Dengue does not kill. What kills is the lack of care and attention to the signs of worsening that can appear, especially when the fever disappears. This neglected moment leads to avoidable serious cases and deaths.
Most of the avoidable deaths from dengue are the result of several errors, three of which stand out. The first is when patients or their families...
Notícias
Data de publicação: 26/02/2024 - 14:21
Since the beginning of the year, infections caused by the Aedes aegypt mosquito, such as dengue and chikungunya, have been on the rise. In recent weeks, Acre, Minas Gerais, Goiás and the Federal District have declared a state of emergency following an increase in the number of dengue cases, requiring extra care with the mosquito. Other cities are seeing the numbers rise not only for this disease, but also for chikungunya. The State of S...
Notícias
Data de publicação: 23/02/2024 - 15:01
The suicide rate among young people grew by 6% a year in Brazil between 2011 and 2022. In turn, notification rates for self-injuries in the 10-24 age group increased by 29% every year in the same period. The figure was higher compared to the general population, whose suicide rate grew by an average of 3.7% a year and self-injury by 21% a year over the same period. These results were found in the analysis of a set of nearly 1 million data points...
Notícias
Data de publicação: 03/04/2024 - 14:29
Fiocruz, through the Institute of Drug Technology (Farmanguinhos/Fiocruz) and the René Rachou Institute (IRR/Fiocruz Minas), has signed a partnership agreement for research, development and innovation (RD&I) with the French pharmaceutical company Servier. The aim is to enable research into cancer treatments using natural samples. The event was attended by the presidents of France, Emmanuel Macron, and of Fiocruz, Mario Moreira....
Notícias
Data de publicação: 20/02/2024 - 15:57
The production of vaccines and diagnostic kits and the use of Wolbachia mosquitoes on a large scale were topics that led to the visit of the Nigerian and Indonesian Health ministers to Fiocruz on 2/8. With different agendas, they visited the Manguinhos Campus in Rio de Janeiro at different times and took part in meetings with members of the Foundation's units.
The similarities in health challenges between countries and the process of...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
